Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hypertension: antihypertensive class matters for combination therapy.

× No keyword cloud information.

8 in total

1. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.

Authors: George L Bakris; Pantelis A Sarafidis; Matthew R Weir; Björn Dahlöf; Bertram Pitt; Kenneth Jamerson; Eric J Velazquez; Linda Staikos-Byrne; Roxzana Y Kelly; Victor Shi; Yann-Tong Chiang; Michael A Weber
Journal: Lancet Date: 2010-02-18 Impact factor: 79.321

2. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Authors: Björn Dahlöf; Peter S Sever; Neil R Poulter; Hans Wedel; D Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal: Lancet Date: 2005 Sep 10-16 Impact factor: 79.321

3. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.

Authors: Bryan Williams; Peter S Lacy; Simon M Thom; Kennedy Cruickshank; Alice Stanton; David Collier; Alun D Hughes; H Thurston; Michael O'Rourke
Journal: Circulation Date: 2006-02-13 Impact factor: 29.690

4. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.

Authors: Giuseppe Mancia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry Aj Struijker Boudier; Alberto Zanchetti
Journal: J Hypertens Date: 2007-09 Impact factor: 4.844

5. Composite renal endpoints: was ACCOMPLISH accomplished?

Authors: Hiddo Lambers Heerspink; Dick de Zeeuw
Journal: Lancet Date: 2010-02-18 Impact factor: 79.321

6. Effects of combination therapy with captopril and nifedipine in severe or resistant hypertension.

Authors: W B White; J J Viadero; T J Lane; S Podesla
Journal: Clin Pharmacol Ther Date: 1986-01 Impact factor: 6.875

7. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190

8. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

Authors: Kenneth Jamerson; Michael A Weber; George L Bakris; Björn Dahlöf; Bertram Pitt; Victor Shi; Allen Hester; Jitendra Gupte; Marjorie Gatlin; Eric J Velazquez
Journal: N Engl J Med Date: 2008-12-04 Impact factor: 91.245

8 in total

1 in total

1. Minocycline synergizes with N-acetylcysteine and improves cognition and memory following traumatic brain injury in rats.

Authors: Samah G Abdel Baki; Ben Schwab; Margalit Haber; André A Fenton; Peter J Bergold
Journal: PLoS One Date: 2010-08-31 Impact factor: 3.240

1 in total